References
- Dunkel I J, Garvin J H, Goldman S. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. J Neurooncol 1998; 37: 67–73
- Grill I, Kalifa C, Doz F. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma: a phase II study. Pediatr Neurosurg 1996; 25: 7–12
- Mason W P, Goldman S, Yates A J. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma: a report of the Childrens Cancer Group. J Neurooncol 1998; 37: 135–143
- Dupuis-Girod S, Hartmann O, Benhamou E. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma. J Neurooncol 1996; 27: 87–98
- Graham M L, Herndon J E, III, Casey J R. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 1997; 15: 1814–1823
- Dunkel I J, Boyett J M, Yates A. High dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 1998; 16: 222–228
- Belza M G, Donaldson S S, Steinberg G K. Medulloblastoma: freedom from relapse longer than 8 years-a therapeutic cure. J Neurosurg 1991; 75: 575–582
- Torres C F, Rebsamen S, Silber J H. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994; 330: 892–895